Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.

Uveitis

Conference

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Modern Retina® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the retinal and ophthalmic communities.

AAO 2020: Study confirms Phase III results for uveitis treatment